Subcutaneous injection of the HIV-1 fusion inhibitor Enfuvirtide (FUZEON) may result in soft-tissue accumulation of Tc-99m MDP

L. E. Pack, Lionel S. Zuckier

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Subcutaneous injection of the HIV-1 fusion inhibitor Enfuvirtide (FUZEON) may result in soft-tissue accumulation of Tc-99m MDP'. Together they form a unique fingerprint.

Medicine & Life Sciences